Gleason Group »

Actuate Therapeutics shares owned by Gleason Group

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Gleason Group from 13F filings

Historical chart of Gleason Group investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Gleason Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Gleason Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $117k 19k 6.12
2025-09-30 $127k 19k 6.69
2025-06-30 $116k 19k 6.11